Anavex Life Sciences Total Liabilities

Anavex Life Sciences (AVXL) currently reports a total liabilities of $7.7M as of June 2026. That compares with $11M in the prior-year period — down 33.0% year over year. Use the charts on this page to explore Anavex Life Sciences's total liabilities history and peer comparisons.

Anavex Life Sciences's total liabilities decreased from $11M to $7.7M — a 33.0% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Anavex Life Sciences reported $7.7M in total liabilities as of June 2026. That compares with $11M in the prior-year period — down 33.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $7.7M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Anavex Life Sciences, and consider following AVXL for alerts when major investors trade the stock.

Anavex Life Sciences is classified in the Healthcare sector. On total liabilities, it currently shows $7.7M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing AVXL with unrelated industries.